The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinics.
BACKGROUND
Designing optimal antiretroviral (ARV) salvage regimens for multiclass drug-resistant, human immunodeficiency virus (HIV)-infected patients demands specific clinical skills. Our aim was to assess the virologic and immunologic effects of the treatment recommendations drafted by a peer advisory board to physicians caring for heavily ARV-experienced patients.


METHODS
We conducted a nationwide, HIV clinic-based, cohort study in Mexico. Adults infected with HIV were assessed for a median of 33 months (interquartile range [IQR] = 22-43 months). These patients had experienced the virologic failure of at least 2 prior ARV regimens and had detectable viremia while currently being treated; their physicians had received therapeutic advice, by a panel of experts, regarding the ARV salvage regimen. The primary endpoint was the incidence of loss of virologic response (plasma HIV-RNA levels of <200 copies per mL, followed by levels above this threshold) during the follow-up assessment using an observed-failure competing risks regression analysis.


RESULTS
A total of 611 patients were observed (median ARV therapy exposure = 10.5 years; median prior regimens = 4). The probabilities of virologic failure were 11.9%, 14.4%, 16.9%, and 19.4% at the 12-, 24-, 36-, and 48-month follow-up assessments, respectively. Of the 531 patients who achieved a confirmed plasma HIV-RNA level below 200 copies per mL, the median increase in blood CD4(+) T-cell count was 162 cells per mL (IQR = 45-304 cells per mL).


CONCLUSIONS
In routine practice, a high rate of patients with extensive ARV experience, who received an optimized salvage regimen recommended by a peer advisory committee, achieved a long-term sustained virologic response and immune reconstitution.
Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," México City , México.
Juan J
JJ
Calva
Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," México City , México.
Juan
J
Sierra-Madero
Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," México City , México.
Luis E
LE
Soto-Ramírez
Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," México City , México.
Pedro
P
Aguilar-Salinas
HIV; Mexico; antiretroviral; peer advice; resistance